Holen Sie sich die Stockscreener-App
315.74
5.31%
-17.72
Handel nachbörslich:
315.94
0.20
+0.06%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CI?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$333.46
Offen:
$324.08
24-Stunden-Volumen:
3.56M
Relative Volume:
2.09
Marktkapitalisierung:
$88.96B
Einnahmen:
$254.47B
Nettoeinkommen (Verlust:
$5.03B
KGV:
17.48
EPS:
18.06
Netto-Cashflow:
$6.01B
1W Leistung:
-5.19%
1M Leistung:
-4.38%
6M Leistung:
-7.10%
1J Leistung:
-9.37%
1-Tages-Spanne:
$309.59
$328.25
1-Wochen-Bereich:
$309.59
$337.25
52-Wochen-Spanne:
$262.03
$370.82
Cigna Group Stock (CI) Company Profile
Firmenname
Cigna Group
Sektor
Branche
Telefon
(860) 226-6000
Adresse
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Vergleichen Sie CI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
315.74 | 88.96B | 254.47B | 5.03B | 6.01B | 18.06 |
|
UNH
Unitedhealth Group Inc
|
378.75 | 367.22B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
416.69 | 94.06B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CVS
Cvs Health Corp
|
64.81 | 84.88B | 378.96B | 5.28B | 5.94B | 4.19 |
|
HUM
Humana Inc
|
252.86 | 30.98B | 117.76B | 1.21B | 2.39B | 9.95 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-06 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-02-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-02-05 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-02-01 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-01-04 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2023-12-11 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-06-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-04-05 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-01-03 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-11-21 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-07-14 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-22 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Hold |
| 2022-05-27 | Fortgesetzt | Bernstein | Mkt Perform |
| 2022-05-26 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-05-16 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-05-09 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-02-07 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-02-04 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-17 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-10 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-06 | Bestätigt | BofA Securities | Buy |
| 2021-08-06 | Bestätigt | Citigroup | Buy |
| 2021-08-06 | Bestätigt | Deutsche Bank | Buy |
| 2021-08-06 | Bestätigt | Jefferies | Buy |
| 2021-08-06 | Bestätigt | Mizuho | Buy |
| 2021-08-06 | Bestätigt | Oppenheimer | Outperform |
| 2021-08-06 | Bestätigt | Truist | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-03-24 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-12-11 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-08-06 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2019-04-23 | Eingeleitet | UBS | Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-24 | Eingeleitet | Edward Jones | Buy |
| 2018-03-13 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-03-08 | Eingeleitet | Barclays | Overweight |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2017-11-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-06-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-06-12 | Eingeleitet | Credit Suisse | Outperform |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-05-08 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
Alle ansehen
Cigna Group Aktie (CI) Neueste Nachrichten
Cigna Hit With Proposed Class Action Over Online Tracking Pixels - Bloomberg Law News
Stock Movers: Carnival, NRG Energy, Cigna - Bloomberg.com
Cigna Group (CI) Price Target Raised by Truist Securities | CI S - GuruFocus
The Cigna Group (CI) Shares Down 6.47% on May 12 - GuruFocus
Cigna (CI) Shares Dip on Presidential Push Against Drug Middleme - GuruFocus
Cigna, CVS down as Trump targets 'drug middlemen' in drug prices EO - Seeking Alpha
Cigna (CI) Receives Price Target Boost from Truist Analyst | CI Stock News - GuruFocus
Cigna (CI) Could Be Influenced by Proposed Medicaid Changes | CI Stock News - GuruFocus
Health insurance company denies operation to man battling lung cancer - KHOU
Man Fighting Cancer Now Battling Insurance Company After Life-Saving Transplant Denied - Men's Journal
Cigna lung transplant denial: Insurance company denies Deron Wells, Santa Monica, CA man with lung cancer, life-saving transplant - ABC7 Chicago
We Think Cigna Group's (NYSE:CI) Robust Earnings Are Conservative - simplywall.st
Cigna Group's (NYSE:CI) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
Cigna insurance denies Santa Monica man a life-saving lung transplant as he was preparing to fly cross-country for procedure - ABC7 Los Angeles
The Cigna Group (CI): Among the Cheap ESG Stocks to Buy According to Hedge Funds - Yahoo Finance
11 Cheap ESG Stocks to Buy According to Hedge Funds - Insider Monkey
Cigna stock price target raised to $373 by Bernstein - Investing.com India
RBC Capital Adjusts Cigna Group Price Target to $371 From $355 - marketscreener.com
Cigna Group (CI) Stock Target Price Raised by Guggenheim | CI Stock News - GuruFocus
CFRA: Cigna Group ’faces industry-wide cost pressures’ By Investing.com - Investing.com South Africa
CFRA: Cigna Group ’faces industry-wide cost pressures’ - Investing.com Australia
Lionbridge Recognized with 2024 Cigna Healthy Workforce Designation™NORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA
Guggenheim Adjusts Cigna Group Price Target to $388 From $384, Maintains Buy Rating - marketscreener.com
Cigna (CI) Price Target Increased on Positive Outlook | CI Stock News - GuruFocus
Deutsche Bank Adjusts Cigna Group Price Target to $372 From $356, Maintains Buy Rating - marketscreener.com
Raymond James Raises Price Target on Cigna Group to $385 From $360 - marketscreener.com
Piper Sandler Raises Price Target for Cigna Group (CI) to $374 | CI Stock News - GuruFocus
Cigna Packs Healthy Punch As Q1 Beat Sends Shares Higher, Analysts Raise Targets - Benzinga
Leerink Partners Adjusts Price Target on Cigna Group to $365 From $325, Maintains Market Perform Rating - marketscreener.com
Cigna Group (CI) Maintains "Buy" Rating from Guggenheim | CI Stock News - GuruFocus
CI: Cigna Group Stock Receives Boost from Morgan Stanley Rating | CI Stock News - GuruFocus
Cigna Group (CI) Price Target Raised by Barclays Analyst | CI St - GuruFocus
Cigna Group (CI) Price Target Raised by Barclays Analyst | CI Stock News - GuruFocus
Morgan Stanley Adjusts Cigna Group Price Target to $390 From $379, Maintains Overweight Rating - marketscreener.com
TD Cowen Adjusts Cigna Group Price Target to $386 From $380, Maintains Buy Rating - marketscreener.com
Jefferies & Co Adjusts Cigna Group Price Target to $397 From $376, Maintains Buy Rating - marketscreener.com
Cigna (CI) Target Price Increased by TD Cowen | CI Stock News - GuruFocus
Piper Sandler Elevates Cigna (CI) Price Target Amid Strong Performance | CI Stock News - GuruFocus
Cigna (CI) Price Target Raised by Morgan Stanley Analyst | CI Stock News - GuruFocus
Cigna (CI) Sees Price Target Increase Following Promising Q1 Results | CI Stock News - GuruFocus
Jefferies lifts Cigna stock price target to $397, maintains buy rating - Investing.com
Cigna (CI) Target Price Raised by Barclays Analyst | CI Stock Ne - GuruFocus
Cigna (CI) Target Price Raised by Barclays Analyst | CI Stock News - GuruFocus
Cigna raises 2025 outlook after lower-than-expected cost trends - MSN
MHE Week in Review –Cigna Revenue Increase, Aetna’s Exit and More - Managed Healthcare Executive
The Return Trends At Cigna Group (NYSE:CI) Look Promising - Yahoo Finance
The Cigna Group (CI) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Raised EPS Guidance - Yahoo Finance
The Cigna Group (CI) Q1 2025 Earnings Call Highlights: Strong Re - GuruFocus
Cigna Reports Strong Q1 2025 Results and Raises Outlook - TipRanks
Decoding The Cigna Group (CI): A Strategic SWOT Insight - GuruFocus
Cigna: Q1 Earnings Snapshot - MySA
Finanzdaten der Cigna Group-Aktie (CI)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.23%
2.99%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):